Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

I care deeply because this chronic disease is mine. It lives inside me. It’s radically changed my life and the life of my ...

Proton pump inhibitors (PPIs) are among the most widely used medications in the U.S., familiar to many through brand names ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

A genetically engineered pig kidney helped Towana Looney enjoy 130 days without the need for dialysis before the organ was ...

The results showed that people taking rosuvastatin were more likely to develop signs of kidney damage than those taking ...

"By 2040, Chronic Kidney Disease (CKD) will rank 5th in global mortality ... with its product qualified late-2024 as a co-primary endpoint by the FDA"concludes Luc-Emmanuel Barreau, Partner at Red ...

UCLA researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker ...